Algernon Pharmaceuticals Inc (AGNPF)

[namah sivaya]

and of course dilution is coming.......

"At present, the Company has no current operating income. Without additional financing, the Company may not be able to fund its ongoing operations and complete development activities. The Company
intends to finance its future requirements through a combination of debt and/or equity issuance."

no wonder they don't have enough $ with spending on stock marketing, consulting fees, etc...

"During the nine months ended May 31, 2017, the Company incurred shareholder communications expenses of $47,122 and marketing expenses of $63,470 (nine months ended May 31, 2016 - $90,955 and $311,815 respectively)."

spending down recently but most likely will need to ramp up marketing again if going to sell more stock. could be why the stock is continuous fade....